|
Timothy G. Biro is Managing Partner of Ohio Innovation Fund, I,
LP, and a General Partner with Reservoir Venture Partners
recently presented a lecture entitled, “From Pharmacist to
Financier.”
Prior to his career in venture capital, Mr. Biro was with Merck
& Co., holding management positions and most recently served as
superintendent of Pharmaceutical Manufacturing. Prior to Merck,
Mr. Biro worked in cancer research at Hershey Medical Center and
in business planning in the Chemical Products Group of FMC
Corporation.
Both Ohio Innovation Fund and Reservoir Venture Partners focus
on investing in early-stage technology-based companies including
biotechnology and medical devices, information technologies, and
advanced materials.
Mr. Biro currently serves on the Board of Directors of DATATRAK
(Nasdaq; DATA), a provider of Electronic Data Capture (EDC)
software and services to the biopharmaceutical industry. He also
serves on the Board of Directors for several private company
boards including Imalux, a medical imaging company which has
developed OCT technology for the early detection of bladder
cancer and as an imaging guide for nerve sparing
prostatectomies, FLX Micro, a producer of silicon carbide MEMS
devices for harsh environments, and SpineMatrix, which has
developed a non-invasive device for diagnosis and monitoring of
lower back injury.
He currently is CEO for OncoImmune, a biopharmaceutical company
developing therapeutics for Multiple Sclerosis and Tuberous
Sclerosis. He serves on the Industrial Advisory Board for the
Cleveland Clinic as well as on the Advisory Board for the Ohio
Venture Association. He is also Chairman of the Board of
Advisors for BioOhio, the advocacy group for the promotion of
the Life Sciences industry in Ohio.
He holds a BS in Microbiology from Pennsylvania State
University, a BS in Pharmacy from Temple University, and a MBA
in Finance and Marketing from the Wharton School of Business.
The lecture was supported by a grant from the Temple University
Alumni Association to “stimulate greater activity between
prominent alumni and faculty, students and other alumni with the
University community; to highlight distinguished alumni; and to
increase visibility of and serve as a cultivation tool for
sponsoring schools and colleges.




|